Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KD-406 Clinical Pharmacology Study
jRCT2080224697Phase 1Completed
- Sponsor
- KM Biologics
- Start
- May 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of KD-406 in Flaviviral diseases (3 arms), sponsored by KM Biologics. Primary endpoints: Tolerability and safety of KD-406 and Immunogenicity of KD-406. Started May 2019; status: completed.
02
Drugs
KD-406
03
Conditions
Flaviviral diseases
Beyond the preview
Go deeper on jRCT2080224697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224697.